Rejuva Fresh has received Health Canada approval for its PicoPretty laser platform, reflecting continued growth in non-invasive aesthetic treatments and broader access to regulated medical devices.
Rejuva Fresh has announced that its PicoPretty Q-Switched ND Laser has received Health Canada approval, allowing the system to be offered to medical spas and aesthetic clinics across the country. The regulatory clearance represents more than a product milestone, as it expands the range of licensed technologies available to practitioners performing non-invasive cosmetic procedures. As demand for aesthetic treatments continues to grow, regulatory approvals remain an important step in ensuring that clinics have access to devices that meet national standards for medical use.
Non-invasive laser procedures have become an increasingly significant part of modern aesthetic medicine, offering alternatives to more invasive cosmetic interventions. Treatments for pigmentation, tattoo removal, skin rejuvenation, vascular concerns, and hair reduction have grown in popularity as technology has improved precision while reducing recovery times. For clinics, versatile laser platforms are particularly valuable because they allow multiple treatment types to be performed using a single system, helping practices respond to a wider variety of patient needs without investing in separate devices for each application.
According to Rejuva Fresh, the PicoPretty platform combines picosecond, long-pulse, and Genesis laser technologies into one device. The company states that the system is designed to treat all Fitzpatrick skin types and supports applications including tattoo removal, pigmentation correction, collagen stimulation, vascular treatments, and hair reduction. Rejuva Fresh also highlights engineering features such as integrated water temperature and flow monitoring, premium optical components, and an external filter intended to simplify maintenance. While these capabilities are positioned as practical advantages for providers, the Health Canada approval primarily signifies that the device can now be marketed and used within Canada’s regulated medical aesthetics sector.
The approval also reflects the increasing pace of innovation within the aesthetic device industry. Manufacturers are placing greater emphasis on multifunctional systems that combine several treatment modalities while incorporating monitoring features designed to support consistent operation and patient safety. As regulatory agencies evaluate these increasingly sophisticated technologies, approvals play a key role in balancing innovation with oversight.
Rejuva Fresh’s latest regulatory milestone illustrates how advances in aesthetic medicine are gradually becoming more accessible through established clinical channels. As non-invasive procedures continue to evolve, approvals such as this help expand the range of treatment options available to practitioners while reinforcing the importance of regulated medical technology in a rapidly growing field.
